Tuberculosis (TB) Blood Test (IGRA)
This fact sheet introduces the TB blood test, also called an Interferon Gamma Release Assay or IGRA.
This fact sheet introduces the TB blood test, also called an Interferon Gamma Release Assay or IGRA.
The STOP TB Partnership's theme for World TB Day 2010 is "On the Move Against Tuberculosis: Innovate to accelerate action." This year's campaign will focus on individuals around the world who have found new ways to stop TB and can serve as an inspiration to others. The idea is to recognize people who have introduced a variety of innovations in a variety of settings.
This new report on anti-tuberculosis (TB) drug resistance by the World Health Organization (WHO) updates “Anti-tuberculosis drug resistance in the world: Report No. 4” published by WHO in 2008. It summarizes the latest data and provides latest estimates of the global epidemic of multidrug and extensively drug-resistant tuberculosis (M/XDR-TB). For the first time, this report includes an assessment of the progress countries are making to diagnose and treat MDR-TB cases.
The Truth About TB website is part of a new campaign to get people talking and thinking about TB. The campaign is being developed by TB Alert, the UK's national Tuberculosis charity. The website includes stories by people who have been affected by TB, questions and answers about TB, and a variety of resources.
Popularly known as “The Orange Guide”, the 6th edition of this small book provides practical guidance to health workers on the front line of TB control. It includes sections on HIV, MDR-TB and a review of the recommended treatment regimens.
This tool estimates the risk of active tuberculosis for an individual with a tuberculin skin test reaction of 5+mm, based on his/her clinical profile. It is intended for adults tested with standard tuberculin (5 TU PPDS, or 2 TU RT-23).
This book provides guidelines to national TB program managers, policy makers, nongovernmental organizations, and donor agencies on effective management of TB. The guidelines focus on the technical and managerial aspects of treatment.
This book is the first title in Wiley-Blackwell's new 'Infection Biology Series'. Early chapters focus on immunology and the problems facing vaccination strategies for both diseases. Later chapters deal with some of the most threatening consequences of this co-infection, such as the emergence of drug resistant TB.
This set of online materials can be used by instructors in the core public health disciplines (Epidemiology, Biostatistics, Health Policy and Management, Environmental Health Sciences, and Social and Behavioral Sciences). The materials can help provide important and sometimes neglected content on the prevention and control of TB to graduate level public health students.
This publication, with contributions from over 30 experts, aims to provide a comprehensive, well-referenced blueprint to guide researchers, clinicians, industry partners, academics, and TB controllers in all sectors in all aspects of TB diagnostics development, from concept to evaluation, implementation, scale-up, delivery and impact.